Replies to post #60961 on Biotech Values

[genisi]

Pfizer said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm.

http://finance.yahoo.com/news/Pfizer-enters-melanoma-apf-1895588390.html?x=0&.v=1